Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 135691, 15 pages
http://dx.doi.org/10.1155/2015/135691
Research Article

High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair

1Department of Pathophysiology, Poznan University of Medical Sciences, Rokietnicka 8 Street, 60-806 Poznan, Poland
2Department of Toxicology, Poznan University of Medical Sciences, Dojazd 30 Street, 60-631 Poznan, Poland
3Department of Chemical Technology of Drugs, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznan, Poland
4Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Pasteura 3, 02-093 Warsaw, Poland
5Division of Gynecological Surgery, Poznan University of Medical Sciences, Polna 33 Street, 60-535 Poznan, Poland

Received 8 April 2015; Revised 7 June 2015; Accepted 14 June 2015

Academic Editor: Gabriele Saretzki

Copyright © 2015 Justyna Mikuła-Pietrasik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Justyna Mikuła-Pietrasik, Patrycja Sosińska, Marek Murias, et al., “High Potency of a Novel Resveratrol Derivative, 3,3′,4,4′-Tetrahydroxy-trans-stilbene, against Ovarian Cancer Is Associated with an Oxidative Stress-Mediated Imbalance between DNA Damage Accumulation and Repair,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 135691, 15 pages, 2015. https://doi.org/10.1155/2015/135691.